Ring-fused compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8987473
APP PUB NO 20140005221A1
SERIAL NO

13982200

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SATO PHARMACEUTICAL CO LTD5-27 MOTOAKASAKA 1-CHOME MINATO-KU TOKYO 107-0051

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baba, Motoaki Kawasaki, JP 6 26
Fujioka, Shinichi Tokyo, JP 4 26
Itoh, Yoshiki Tsukuba, JP 19 176
Kondoh, Eri Yokohama, JP 4 26
Nagai, Keita Matsudo, JP 17 80
Nagasawa, Koh Tokyo, JP 6 30
Takahashi, Hirobumi Ushiku, JP 15 78
Tanaka, Kenichi Ushiku, JP 309 3206

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00